In spite of AD etiology not being understood in full, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition have been adopted as an efficacious preventive and managerial approach of AD treatment (Adeowo et al., 2020). The gene discussed is ACHE; the disease is Alzheimer disease.